Screener
Arcutis Biotherapeutics, Inc. ARQT Business Segments — Total Operating Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of sales | 10,939 | 7,492 | 20,723 | 16,322 |
| Research and development | 20,355 | 19,453 | 50,982 | 36,996 |
| Selling, general and administrative | 82,138 | 69,170 | 156,214 | 133,172 |
| Total operating expenses | 113,432 | 96,115 | 227,919 | 186,490 |
| Income (loss) from operations | 16,429 | (14,611) | 7,340 | (39,140) |
| Other income (expense): | ||||
| Interest income | 2,279 | 2,076 | 4,554 | 4,613 |
| Interest expense | (3,406) | (3,029) | (7,774) | (6,011) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses?
- Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — total operating expenses of $113.43M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses increased by 18.0% year-over-year, from $96.12M to $113.43M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses has grown at a 8.3% compound annual growth rate (CAGR), from $305.31M to $388.3M.
- What does business segments — total operating expenses mean?
- The aggregate of all operating costs, including cost of sales, R&D, SG&A, and other segment-specific expenses. This metric provides a comprehensive view of the total capital required to maintain the segment's ongoing business operations.
Ask your AI about Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude